Cyanide

Cyanide

SCHEMBL25407948

C#N.C#N.Cn1c(=O)n(C2CC2)c2cc(C=NN)ccc21

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ GAA P10253 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ HPD P32754 3/20 0.42
▸ ALDH1A1 P00352 5/20 0.42
▸ HPGD P15428 4/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ DRD2 P14416 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ PIK3CA P42336 9/20 0.37
▸ PRKDC P78527 9/20 0.37
▸ MTOR P42345 3/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ MAPT P10636 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyanide SCHEMBL25408765 0.95 DRD2 (0.43) KDM4ESMN1; SMN2GAAHTTHPD
Cyanide SCHEMBL25405959 0.84 PRKDC (0.35) KDM4ESMN1; SMN2GAAHTTHPD
Cyanide SCHEMBL25405735 0.84 HPD (0.44) KDM4EGAAHTTHPDALDH1A1
Cyanide SCHEMBL22130246 0.84 ALDH1A1 (0.57) KDM4ESMN1; SMN2GAAHTTALDH1A1
Cyanide SCHEMBL25406040 0.82 SLC6A2 (0.33) KDM4ESMN1; SMN2GAAHTTALDH1A1
Cyanide SCHEMBL25405718 0.82 OPRL1 (0.40) KDM4EGAAHTTHPDALDH1A1
Cyanide SCHEMBL25407432 0.80 PIK3CA (0.39) HTTHPGDHSD17B10PIK3CAPRKDC
Cyanide SCHEMBL25407911 0.77 KDM4E (0.44) KDM4ESMN1; SMN2GAAHTTHPD
Cyanide SCHEMBL25405741 0.77 KDM4E (0.44) KDM4ESMN1; SMN2GAAHTTHPD
Cyanide SCHEMBL25407957 0.76 KDM4E (0.43) KDM4ESMN1; SMN2GAAHTTHPD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT KDM4E 2516/4885SMN1; SMN2 3827/4885GAA 2829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback